Nuacht
PURPOSETo examine the impact of TP53 gain-of-function (GOF) and non-GOF mutations on prognosis of advanced pancreatic ductal adenocarcinoma (PDAC) among patients with KRAS, CDKN2A, and SMAD4 ...
In metastatic CRC, classifying p53 mutations as gain of function or non gain of function may predict sidedness dependent prognosis.
Tá torthaí a d'fhéadfadh a bheith dorochtana agat á dtaispeáint faoi láthair.
Folaigh torthaí dorochtana
Aiseolas